Creabilis appoints George Horner as chairman
This article was originally published in Scrip
Executive Summary
Creabilis (Luxembourg), a clinical-stage biotechnology company creating drugs to treat dermatological disorders, has appointed George Horner as its chairman. He has more than 40 years' industry experience, having most recently served as CEO of Prestwick Pharmaceuticals, which was sold to Biovail and Ovation Pharmaceuticals in late 2008. Before that, Mr Horner was CEO of Vicuron, which was sold to Pfizer for $1.9 billion in 2005.